Knowledge Center

Presentation / Sep 10, 2015

Screening methodologies to expedite the formulation development of amorphous solid dispersions

Authors:
  • Iris Duarte
  • João Henriques
  • João F. Pinto
  • Marcio Temtem
Source:
2015 APS Presentation, Íris Duarte

Related links

2015 APS Presentation - Screening methodologies

Also in the Knowledge Center

Related Content

Devices

Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more

Sunriser® DPI

High Performance, High-Dose Capsule DPI.

Page
Read more

API

Hovione inhalation grade APIs bring unique controlled performance to your formulation.

Page
Read more